Although the dysregulation of CHD family genes has been examined and documented in a broad range of cancers, the roles of CHD-type chromatin remodellers in NSCLC, the predominant type of lung cancer, are poorly understood. This evidence concerns the gene CHDH and non-small cell lung carcinoma.